Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Debates Proposed Rules To Enforce Internet Drug Sales Ban

This article was originally published in PharmAsia News

Executive Summary

Japanese pharmacies have called for a ban on Internet sales of over-the-counter drugs as Internet companies battle against a new law set to take effect next June. The Revised Japanese Pharmaceutical Law would ban such sales, but moves for associated enforcement regulation have prompted a controversy. Internet companies Yahoo and Rakuten, with the support of the Japan Online Drugstore Association, have petitioned the health ministry to block the regulations. The Japan Association of Chain Drug Stores is leading a call in support of the government plans. (Click here for more

You may also be interested in...



Japan Clamps Down on Internet OTC Drug Sales

TOKYO - Most over-the-counter drugs available in Japan will no longer be available through parcel delivery service beginning June 1. Japan's Ministry of Health, Labor and Welfare defends its move saying consumers can more safely purchase OTC drugs when given face-to-face advice by pharmacists at drug stores

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067426

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel